Imgatuzumab Uses, Dosage, Side Effects and more
Imgatuzumab is under investigation in clinical trial NCT01326000 (A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer).
| Attribute | Details |
|---|---|
| Trade Name | Imgatuzumab |
| Generic | Imgatuzumab |
| Imgatuzumab Other Names | Imgatuzumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
